Top Markets
#1 Seeker Seeker +125.76%
#2 AI XOVIA AI XOVIA +108.37%
#3 MowCat MowCat +106.88%
#4 Helium Helium +78.29%
#5 Pons Pons +45.97%
#6 UnifAI Network UnifAI Network +35.36%
#7 Zora Zora +32.41%
#8 Bounce Bounce +21.84%
#9 Zylo Ecosystem Zylo Ecosystem +20.33%
#10 Tensor Tensor +16.98%
Coin of the day
Seeker Seeker
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Hvsen Biotechnology Co., Ltd. Hvsen Biotechnology Co., Ltd.

Hvsen Biotechnology Co., Ltd.

300871
Clasificación en acciones #11646
Hvsen Biotechnology Co., Ltd. is a company based in Wuhan, China, that focuses... Hvsen Biotechnology Co., Ltd. is a company based in Wuhan, China, that focuses on the global research, development, and manufacturing of macrolide active pharmaceutical ingredients (APIs) and finished drug products. The company's diverse product portfolio features tylvalosin, offered in both raw material form and various preparations, along with florfenicol preparations and a broader selection of other macrolide-based offerings. Additionally, Hvsen produces a range of veterinary pharmaceuticals, available as both raw ingredients and finished drugs, alongside traditional Chinese medicine extracts.
Precio por acción
$3.35
Última sincronización: 2026-08-28
Capitalización bursátil
$675.48M
Cambio (1 día)
0.26%
Cambio (1 año)
5.11%
País
CN
Comercio Hvsen Biotechnology Co., Ltd. (300871)

Categoría

Healthcare
Ganancias de Hvsen Biotechnology Co., Ltd. (300871)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Hvsen Biotechnology Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Hvsen Biotechnology Co., Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH